Skip to main content

Table 3 Summary of proposed mechanisms

From: A systematic review and meta-analysis of acupuncture for improving learning and memory ability in animals

Study

Findings or proposed mechanisms

Bao 2014 [18]

• Reduced apoptosis of hippocampal neurons

• Promoted restoration of damaged nerve cells

Chen 2015 [20]

• Reduced Nogo-A and NgR

Chen 2006 [21]

• Increased GABA

• Reduced Glu

Dai 2015 [22]

• Increased NEP

Hou 2013 [23]

• Increased MR

• Reduced GR

Gao 2012 [24]

• Increased DA, 5-HT and NE

Huang 2010 [25]

• Increased BDNF

Ji 2011 [26]

• Reduced MDA

• Increased SOD

Jia 2011 [27]

• Increased Syp, PKC, NMDAR and PKC mRNA

• Reduced mGluRs

Wang 2012 [28]

• Increased NOS

• Reduced MAO

Lin 2008 [29]

• Increased NMDAR-2BmRNA

Luo 2007 [30]

• Decreased NO

Ma 2009 [31]

• Increased CTGF protein and mRNA

Zhang 2014 [32]

• Increased InsR mRNA

Niu 2009 [33]

• Increased SS and AVP

Su 2013 [34]

• Reduced MDA, P53 and P21

• Increased SOD

Tan 2014 [35]

• Increased GAP-43 and c-fos

Tang 2014 [36]

• Increased CHAT protein

Wang 2013 [37]

• Reduced GSK-3β

Wang 2009 [38]

• Reduced ET

• Increased CGRP

Hong 2014 [39]

• Increased CX43, CX32 and CX36

Xu 2006 [40]

• Increased Bcl-2 protein

• Reduced Bax protein and mRNA

Xu 2007 [41]

• Reduced IL-1β and TNF-α

Yi 2014 [42]

• Increased SOD, PKA and pCREB

• Reduced MDA and c-fos

Feng 2013 [44]

• Increased GluR2

Li 2013 [45]

• Reduced MMP-2 and MMP-9

Zheng 2009 [47]

• Increased ChAT

• Reduced TchE

Li 2012 [48]

• Reduced neuron loss

Li 2014 [49]

• Increased BDNF

Lee 2014 [50]

• Stimulated cholinergic enzyme activities

• Regulated BDNF and CREB expression

Zhu 2013 [51]

• Up-regulated mTOR and eIF4E

Lu 2014 [52]

• Increased Fos expression

Li 2012 [53]

• increased Bcl-2mRNA

• decreased caspase-3

Guo 2015 [54]

• Down-regulated Notch1 and Hes1 mRNA

Jiang 2015 [55]

• Increased the level of uptake rate of glucose

Shao 2008 [56]

• Regulated the amount of AVP, SS, and β-EP

Liu 2013 [57]

• Reduced MDA

• Increased SOD

Li 2015 [58]

• Increased the pyramidal neuron number

• Decreased the number of astrocytes

Lu 2008 [59]

• Increased NCAM and ST8SiaII/IVmRNA

  1. Nogo-A neurite growth inhibitor-A, NgR neurite growth inhibitor receptor, GABA γ-aminobutyric acid, Glu glutamic acid, NEP neutral endopeptidase, MR mineralocorticoid receptor, GR glucocorticoid receptor, DA dopamine, 5-HT 5-hydroxytryptamine, NE norepinephrine, BDNF brain-derived neurotrophic factor, MDA malondialdehyde, SOD superoxide dismutase, SYP synaptophysin, PKC Protein kinase C, NMDAR N-methyl-D-aspartate receptor, mGluRs metabolism glutanic acid acceptor, NOS nitric oxide synthase, MAO monoamine oxidase, NO nitric oxide, CTGF connective tissue growth factor, InsR insulin receptor, SS somatostatin, AVP arginine vasopressin, GAP-43 Growth Associated Protein-43, CHAT choline acetyl transferase, GSK- glycogen synthase kinase-3β, ET endothelia, CGRP calcitonin gene-related peptide, CX connexin, IL interleukin, TNF tumor necrosis factor, pCREB phosphorylated cAMP-response element binding, MMP metal matrix proteinase, ChAT choline acetyltransferase, TchE total cholinesterase, CREB cAMP response element-binding protein, mTOR mammalian target of rapamycin, eIF4E eukaryotic translation initiation factor 4E, NCAM neural cell adhesion molecule